Elisa de Stanchina

Also affiliated with Kettering University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.1Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts

Nature Communications(2022)10.1038/s41467-022-29794-4

Top 16%

1.3DataRank

Top 16%55 citations

Jacklynn V. Egger, Shweta S. Chavan, Nicholas D. Socci, Caitlin Byrne Jones, Faruk E. Kombak +19 more

Papers

Driven by 142 papers — median percentile 53. Top paper: “Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade”.

Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade

Cancer Cell(2023)10.1016/j.ccell.2023.03.009

N/A

3.3DataRank · unranked

147 citations

Matthew D. Hellmann, Jennifer L. Sauter, Marissa S. Mattar, Hira Rizvi, Hyung Jun Woo +28 more

NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors

Communications Biology(2020)10.1038/s42003-020-01508-w

N/A

2.2DataRank · unranked

63 citations

Nicolle E. Hofmann, Bryan D. Smith, Igor Odintsov, Morana Vojnic, Irina Linkov +10 more

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3321

N/A

1.9DataRank · unranked

48 citations

Adam J. Schoenfeld, Evan Siau, Yue Christine Lu, Huichun Tai, Ken Suzawa +17 more

Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy

Cancer Research(2021)10.1158/0008-5472.can-21-2964

N/A

1.7DataRank · unranked

51 citations

Hirokazu Taniguchi, Yuan Hao, Andrew Chow, Yingqian A. Zhan, Shweta S. Chavan +21 more

Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1242

N/A

1.5DataRank · unranked

61 citations

Marcus Ruscetti, Zhen Cao, Yu-Jui Ho, Timour Baslan, Min Zou +20 more

Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts

Nature Communications(2022)10.1038/s41467-022-29794-4

Top 16%

1.3DataRank

Top 16%55 citations

Jacklynn V. Egger, Shweta S. Chavan, Nicholas D. Socci, Caitlin Byrne Jones, Faruk E. Kombak +19 more

Pharmacological restoration of GTP hydrolysis by mutant RAS

Nature(2024)10.1038/s41586-024-08283-2

N/A

1.2DataRank · unranked

44 citations

Yasin Pourfarjam, Feng Hu, Diego J. Rodriguez, Alberto Vides, Ben Sang +5 more

Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.09.225

N/A

1.0DataRank · unranked

37 citations

Pang‐Dian Fan, Besnik Qeriqi, Azadeh Namakydoust, Bobby Daly, Linda S. Ahn +9 more

Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition

Nature(2020)10.1038/s41586-019-1884-x

N/A

0.947DataRank · unranked

552 citations

Yulei Zhao, Jordan Aronowitz, Trang T. Mai, Alberto Vides, Besnik Qeriqi +7 more

Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer

Cancer Cell(2021)10.1016/j.ccell.2021.09.008

N/A

0.912DataRank · unranked

437 citations

Àlvaro Quintanal-Villalonga, Vianne R. Gao, Yubin Xie, Viola Allaj, Ojasvi Chaudhary +29 more

ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1

Molecular Cell(2022)10.1016/j.molcel.2022.04.034

N/A

0.841DataRank · unranked

23 citations

Radha Mukherjee, Rona Yaeger, Jieun Son, Jianing Xu, Na Na +22 more

Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer

Cell Reports(2020)10.1016/j.celrep.2020.108444

N/A

0.832DataRank · unranked

256 citations

Allison L. Richards, Fathema Uddin, Christopher H. Hulton, Àlvaro Quintanal-Villalonga, Axel Martin +14 more

Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy

Nature Cancer(2020)10.1038/s43018-020-00139-8

N/A

0.806DataRank · unranked

214 citations

Chirag Krishna, Xiaoxiao Ma, Xin Pei, Ken-Wing Lee, Vladimir Makarov +23 more

Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1863

N/A

0.784DataRank · unranked

185 citations

Hirokazu Taniguchi, Yingqian A. Zhan, Maysun Hasan, Shweta S. Chavan, Fanli Meng +31 more

Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0405

N/A

0.744DataRank · unranked

142 citations

Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun +29 more

EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance

Nature Cancer(2023)10.1038/s43018-023-00553-8

N/A

0.706DataRank · unranked

110 citations

Katherine C. Murphy, Kelly D. DeMarco, Sneha Gopalan, Haibo Liu, Chaitanya N. Parikh +16 more

Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01186-z

N/A

0.685DataRank · unranked

95 citations

Hirokazu Taniguchi, Yingqian A. Zhan, Maysun Hasan, Shweta S. Chavan, Fanli Meng +25 more

Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation

Nature Communications(2024)10.1038/s41467-024-53178-5

N/A

0.677DataRank · unranked

27 citations

Seth McNutt, Chiranjeevi Pasala, Hieu Nguyen, Daniel T. Thornton, Sahil Sharma +27 more

Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2117754119

N/A

0.673DataRank · unranked

88 citations

Camilla Salvagno, Yu-Jui Ho, Matthew Limjoco, Timour Baslan, Sha Tian +9 more

A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin–MLL Inhibition

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0416

N/A

0.668DataRank · unranked

85 citations

Francisco J. Sánchez‐Rivera, Florian Perner, Douglas Barrows, Edward R. Kastenhuber, Yu-Jui Ho +17 more

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers

Nature Communications(2023)10.1038/s41467-022-35592-9

N/A

0.596DataRank · unranked

52 citations

Henry Walch, Jaclyn F. Hechtman, Sydney M. Moyer, Valeria Sgambati, David M. Faleck +23 more

The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3605

N/A

0.593DataRank · unranked

51 citations

Allan J.W. Lui, Whitney J. Sisso, Eric Gladstone, Zebing Liu, Lukas Delasos +10 more

Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers

Science Translational Medicine(2023)10.1126/scitranslmed.adf7006

N/A

0.574DataRank · unranked

45 citations

Vidushi Durani, Amin H. Sabet, Esther Redín, Kenta Kawasaki, Moniquetta Shafer +20 more

Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3322

N/A

0.574DataRank · unranked

45 citations

Zoe Steinsnyder, Vignesh Ravichandran, Kaitlyn Tkachuk, Yelena Kemel, Chaitanya Bandlamudi +16 more

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

Nature Cancer(2023)10.1038/s43018-023-00630-y

N/A

0.553DataRank · unranked

39 citations

Igor Odintsov, Keiji Ishida, Allan J.W. Lui, Masanori Kato, Tatsuya Suzuki +28 more

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.03.013

N/A

0.524DataRank · unranked

32 citations

Marissa S. Mattar, Allan J.W. Lui, Michael Offin, Christopher Kurzatkowski, Lukas Delasos +9 more

TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma

Nature Communications(2022)10.1038/s41467-022-33137-8

N/A

0.510DataRank · unranked

29 citations

Chiara M. Evans, Daniel Zakheim, Eren L. Chu, Alice Yunsi Refermat, Zahra Asgari +18 more

Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors

Molecular Cancer(2022)10.1186/s12943-022-01676-9

N/A

0.510DataRank · unranked

29 citations

Gnana P. Krishnamoorthy, Mahesh Saqcena, Adrián Acuña-Ruíz, Giovanna Revilla, Elisa de Stanchina +6 more

Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State

Cancer Research(2022)10.1158/0008-5472.can-22-1742

N/A

0.510DataRank · unranked

29 citations

Olivera Grbovic-Huezo, Simon Joost, Anupriya Singhal, Melissa Blum, Katherine Wu +11 more

Regional and clonal T cell dynamics at single cell resolution in immune checkpoint blockade

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.27.461389

Top 38%

0.510DataRank

Top 38%6 citations

Andrew Chow, Jennifer L. Sauter, Marissa S. Mattar, Hira Rizvi, Hyung Jun Woo +21 more

CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation

Signal Transduction and Targeted Therapy(2024)10.1038/s41392-024-01908-y

N/A

0.489DataRank · unranked

25 citations

Kenta Kawasaki, Esther Redín, Fathema Uddin, Swanand Rakhade, Vidushi Durani +28 more

gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma

Frontiers in Oncology(2020)10.3389/fonc.2020.01413

N/A

0.489DataRank · unranked

25 citations

Kenneth Stier, Xiaoyu Li, Evelyn Kandov, Elisa de Stanchina, Qing Chang +7 more

Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells

Biomedicine & Pharmacotherapy(2023)10.1016/j.biopha.2023.114494

N/A

0.483DataRank · unranked

24 citations

Du-San Baek, Rachelle Mendoza, Dorothea Robev, Yan Xu, Yehuda Goldgur +7 more

De Novo and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0471

N/A

0.483DataRank · unranked

24 citations

Charles Coleman, Parvathy Manoj, Deniz Demircioğlu, Nisargbhai Shah, Elisa de Stanchina +4 more

KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0994

N/A

0.425DataRank · unranked

16 citations

Jin K. Kim, Chin‐Tung Chen, Chao Wu, Michael R. Marco, Francisco M. Barriga +10 more

Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers

The Oncologist(2023)10.1093/oncolo/oyad247

N/A

0.396DataRank · unranked

13 citations

Ann Maria, Nicolas Toumbacaris, HuiYong Zhao, Katherine E. Kargus, Morgan Bryant +11 more

RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation

Disease Models & Mechanisms(2020)10.1242/dmm.047779

N/A

0.385DataRank · unranked

12 citations

Igor Odintsov, Roger S. Smith, Kota Ishizawa, Allan J. W. Liu, Lukas Delasos +17 more

Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer

Cancer Cell(2025)10.1016/j.ccell.2025.05.010

N/A

0.385DataRank · unranked

11 citations

Mitesh Patel, Oliver Artz, Georgios Vlachos, Shrey Patel, Omar Hayatt +45 more

MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1 -Fusion-Positive Lung Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0025

N/A

0.373DataRank · unranked

11 citations

Igor Odintsov, Adam J. Schoenfeld, Evan Siau, Marissa S. Mattar, Elisa de Stanchina +7 more

Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2024

N/A

0.330DataRank · unranked

8 citations

Allan J.W. Lui, Kota Ishizawa, Isao Miyazaki, Inna Khodos, Kentaro Wakayama +11 more

Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library

Genome Medicine(2022)10.1186/s13073-022-01129-4

Top 55%

0.296DataRank

Top 55%5 citations

Jennifer L. Sauter, Sam E. Tischfield, Jacklynn V. Egger, Shweta S. Chavan, Nisargbhai Shah +14 more

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Nature Communications(2025)10.1038/s41467-025-67643-2

N/A

0.292DataRank · unranked

6 citations

Xinran Tang, Jordan Eichholz, Andrew McPherson, Jasmine Thomas, Karan Nagar +23 more

CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma

Cancer Research(2022)10.1158/0008-5472.can-21-1397

N/A

0.292DataRank · unranked

6 citations

Michael V. Ortiz, Inna Khodos, Marissa S. Mattar, Allan J.W. Lui, Shinji Kohsaka +5 more

Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101818

N/A

0.241DataRank · unranked

4 citations

Dinesh Kumar, Tessa Seale, Santiago Garcia Borrego, Esther Kaplun, Ilinca Aricescu +17 more

CD39 Identifies Tumor-Reactive CD8 T cells in Patients With Lung Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.24.477554

N/A

0.240DataRank · unranked

3 citations

Fathema Uddin, Levi Mangarin, Hira Rizvi, Anton Dobrin, Sam E. Tischfield +31 more

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.101944

N/A

0.208DataRank · unranked

3 citations

Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar +13 more

Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.27.635086

N/A

0.165DataRank · unranked

2 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways

Cell Reports(2025)10.1016/j.celrep.2025.115779

N/A

0.165DataRank · unranked

2 citations

Subhiksha Nandakumar, Nabila Zaman, Prathiksha Prabhakaraalva, Sarah Ann King, Teja Kalidindi +19 more

ERα-LBD, a novel isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.14.464262

N/A

0DataRank · unranked

0 citations

Pasquale Sansone, Vinagolu K. Rajasekhar, Mesruh Turkekul, Vitaly Boyko, Fanli Meng +19 more

1MO Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation

Annals of Oncology(2021)10.1016/j.annonc.2021.08.1997

N/A

0DataRank · unranked

0 citations

Hirokazu Taniguchi, Yu Zhan, Maysun Hasan, Shweta S. Chavan, Fathema Uddin +15 more

Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1119

N/A

0DataRank · unranked

168 citations

Igor Odintsov, Madelyn Espinosa-Cotton, Inna Khodos, Whitney J. Sisso, Marissa S. Mattar +17 more

Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0062

N/A

0DataRank · unranked

57 citations

Jaclyn E. McCloskey, Huan Yang, Janusz Puc, Yago Alcaina, Yogindra Vedvyas +7 more

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

Cell Reports(2022)10.1016/j.celrep.2022.110814

N/A

0DataRank · unranked

134 citations

Rebecca Caeser, Shweta S. Chavan, Yingqian A. Zhan, Andrew Chow, Parvathy Manoj +15 more

Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.05.014

N/A

0DataRank · unranked

131 citations

Hirokazu Taniguchi, Joseph M. Chan, Yingqian A. Zhan, Xiaoping Chen, Juan Qiu +13 more

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway

Nature Communications(2021)10.1038/s41467-021-27093-y

N/A

0DataRank · unranked

88 citations

Emanuela Ferraro, Anton Safonov, Cristina Bernadó Morales, Enrique J. Arenas, Qing Li +10 more

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1726

N/A

0DataRank · unranked

166 citations

Baishan Jiang, Jiaye Guo, Hong Shao, Isabella Del Priore, Qing Chang +20 more

Diverse alterations associated with resistance to KRAS(G12C) inhibition

Nature(2021)10.1038/s41586-021-04065-2

N/A

0DataRank · unranked

452 citations

Yonina R. Murciano‐Goroff, Jenny Y. Xue, Agnes Ang, Jessica Lucas, Trang T. Mai +23 more

Design of BET Inhibitor Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities

ChemRxiv(2020)10.26434/chemrxiv.13241966

N/A

0DataRank · unranked

0 citations

Jannik N. Andersen, Kyriakos D. Economides, Michail Shipitsin, Olga Burenkova, James Ackley +25 more

Design of BET Inhibitor Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities

ChemRxiv(2020)10.26434/chemrxiv.13241966.v1

N/A

0DataRank · unranked

0 citations

Jannik N. Andersen, Kyriakos D. Economides, Michail Shipitsin, Olga Burenkova, James Ackley +25 more

Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition

Blood(2020)10.1182/blood.2020008017

N/A

0DataRank · unranked

36 citations

Mandana T. Manzari, Laurie Herviou, Mariana Da Silva Ferreira, Connor J. Hagen, Hiroto Kiguchi +6 more

Kidney-Targeted Redox Scavenger Therapy Prevents Cisplatin-Induced Acute Kidney Injury

Frontiers in Pharmacology(2022)10.3389/fphar.2021.790913

N/A

0DataRank · unranked

35 citations

Janki Shah, Elizabeth Mercer, Helen S. Tian, Vanessa Thompson, Justin M. Cheung +7 more

Predicting Gemcitabine Delivery by18F-FAC PET in Murine Models of Pancreatic Cancer

Journal of Nuclear Medicine(2020)10.2967/jnumed.120.246926

N/A

0DataRank · unranked

9 citations

Milan Grkovski, Isabella O’Donoghue, Teja Kalidindi, Nagavarakishore Pillarsetty, Eva Burnazi +8 more

ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance

npj Breast Cancer(2022)10.1038/s41523-022-00470-6

N/A

0DataRank · unranked

25 citations

Pasquale Sansone, Vinagolu K. Rajasekhar, Mesruh Turkekul, Vitaly Boyko, Fanli Meng +21 more

Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0427

N/A

0DataRank · unranked

17 citations

Roy Rabbie, Manik Garg, Dianne Lumaquin, Ting Huang, Emily Montal +12 more

A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries

Cancers(2020)10.3390/cancers12061603

N/A

0DataRank · unranked

18 citations

Luca Vincenzo Cappelli, Paul Zumbo, Jude M. Phillip, Zhaoqi Liu, Shuhua Cheng +17 more

A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2110557119

N/A

0DataRank · unranked

14 citations

Chun‐Hao Huang, Francisco J. Sánchez‐Rivera, Margaret C. Kennedy, Darjus F. Tschaharganeh, John P. Morris +15 more

Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts

JCO Precision Oncology(2022)10.1200/po.21.00242

N/A

0DataRank · unranked

9 citations

Henry Walch, Marissa S. Mattar, Walid K. Chatila, Daniela Molena, Vivian E. Strong +10 more

Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer suggests extensive drug penetration through the tumor

Pharmacology Research & Perspectives(2022)10.1002/prp2.898

N/A

0DataRank · unranked

1 citations

Louise M. Fanchon, Hanan Alwaseem, Henrik Molina, Isabella O’Donoghue, Amber Bahr +4 more

EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.21.495523

N/A

0DataRank · unranked

8 citations

Katherine C. Murphy, Yvette Lopez-Diaz, Kelly D. DeMarco, Haibo Liu, Sneha Gopalan +14 more

Molecular characterization of acquired resistance to KRAS G12C inhibition in gastrointestinal cancers

Research Square(2022)10.21203/rs.3.rs-1236956/v1

N/A

0DataRank · unranked

2 citations

Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco +23 more

Pan-KRAS inhibitor disables oncogenic signalling and tumour growth

Nature(2023)10.1038/s41586-023-06123-3

N/A

0DataRank · unranked

506 citations

Lorenz Herdeis, Dorothea Rudolph, Yulei Zhao, Jark Böttcher, Alberto Vides +19 more

STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma

Nature(2023)10.1038/s41586-023-05880-5

N/A

0DataRank · unranked

242 citations

Francisco J. Sánchez‐Rivera, Zhenghan Wang, Gabriela N. Johnson, Yu-Jui Ho, Karuna Ganesh +14 more

Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone

Cell Reports(2020)10.1016/j.celrep.2020.107840

N/A

0DataRank · unranked

63 citations

Hardik J. Patel, Sahil Sharma, Adriana Corben, Tai Wang, Palak Panchal +21 more

Cooperative CAR targeting to selectively eliminate AML and minimize escape

Cancer Cell(2023)10.1016/j.ccell.2023.09.010

N/A

0DataRank · unranked

113 citations

Jorge Mansilla‐Soto, Sarah Nataraj, Friederike Kogel, Qing Chang, Elisa de Stanchina +9 more

TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0571

N/A

0DataRank · unranked

70 citations

Ji Eun Lee, Srinivasaraghavan Kannan, Alison M. Schram, Helen Won, Sophie Shifman +29 more

The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction

Nature Communications(2020)10.1038/s41467-019-14082-5

N/A

0DataRank · unranked

87 citations

Suhasini Joshi, Tai Wang, Alexander Bolaender, Srinivasa Gandu, John Koren +34 more

SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0735

N/A

0DataRank · unranked

109 citations

Luis J. Leandro‐García, Jesper L.V. Mååg, Vatche Tchekmedyian, Gnana P. Krishnamoorthy, Prasanna P. Tamarapu +13 more

Functional Genomics In Vivo Reveal Metabolic Dependencies of Pancreatic Cancer Cells

Cell Metabolism(2020)10.1016/j.cmet.2020.10.017

N/A

0DataRank · unranked

130 citations

Aleksey Chudnovskiy, Lou Baudrier, Benjamin Prizer, Yuyang Liu, Benjamin N. Ostendorf +11 more

Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models

Nature Communications(2023)10.1038/s41467-023-37646-y

N/A

0DataRank · unranked

30 citations

Huan Yang, Yago Alcaina, Janusz Puc, Alyssa Birt, Yogindra Vedvyas +12 more

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer

Cancer Cell(2020)10.1016/j.ccell.2020.06.005

N/A

0DataRank · unranked

256 citations

Wouter R. Karthaus, Young Sun Lee, Vianne R. Gao, Chao Wu, Joshua W. Russo +24 more

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0DataRank · unranked

293 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more

Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.05.007

N/A

0DataRank · unranked

20 citations

Igor Odintsov, Vladimir Markov, Rebecca Caeser, Paweł Sobczuk, Sam E. Tischfield +14 more

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

Cell(2020)10.1016/j.cell.2020.03.008

N/A

0DataRank · unranked

419 citations

John P. Morris, Riccardo Mezzadra, James Russell, Josef Leibold, Paul B. Romesser +15 more

Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma

Nature Communications(2023)10.1038/s41467-023-37216-2

N/A

0DataRank · unranked

14 citations

Mariana Da Silva Ferreira, Tatiana Erazo, Man Jiang, Zahra Asgari, Elisa de Stanchina +3 more

A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0310

N/A

0DataRank · unranked

4 citations

Payal T. Patel, Aleksandr Pankov, Jacob A. Boyer, Rajesh K. Soni, Isabella Del Priore +10 more

FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.30.538578

N/A

0DataRank · unranked

5 citations

Daniel E. Gracilla, Marcus R. Breese, Yone Phar Lin, Filemon S. Dela Cruz, Tamar Y. Feinberg +12 more

Tumorigenesis driven by the BRAF V600E oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.21.568071

N/A

0DataRank · unranked

1 citations

Jacob A. Boyer, Simon F. Roy, Noah A. Outmezguine, Malvika Sharma, Hongyan Li +14 more

Data from CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma

(2023)10.1158/0008-5472.c.6513894.v1

N/A

0DataRank · unranked

0 citations

Michael V. Ortiz, Inna Khodos, Marissa S. Mattar, Allan J.W. Lui, Shinji Kohsaka +5 more

Data from Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy

(2023)10.1158/0008-5472.c.6513732.v1

N/A

0DataRank · unranked

0 citations

Hirokazu Taniguchi, Yuan Hao, Andrew Chow, Yingqian A. Zhan, Shweta S. Chavan +21 more

Data from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

University of Groningen research database (University of Groningen / Centre for Information Technology)(2023)10.1158/0008-5472.c.6513651.v1

N/A

0DataRank · unranked

0 citations

Jianan Lin, Nicolas Lecomte, Prathibha Mohan, Gokce Askan, Viraj R. Sanghvi +21 more

Data from Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

(2023)10.1158/0008-5472.c.6513651

N/A

0DataRank · unranked

0 citations

Jianan Lin, Nicolas Lecomte, Prathibha Mohan, Gokce Askan, Viraj R. Sanghvi +21 more

Data from Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

(2023)10.1158/1078-0432.c.6531197

Top 100%

0DataRank

Top 100%0 citations

Zoe Steinsnyder, Vignesh Ravichandran, Kaitlyn Tkachuk, Yelena Kemel, Chaitanya Bandlamudi +16 more

Data from Imaging Colon Cancer Response Following Treatment with AZD1152: A Preclinical Analysis of [18F]Fluoro-2-deoxyglucose and 3′-deoxy-3′-[18F]Fluorothymidine Imaging

(2023)10.1158/1078-0432.c.6520382

N/A

0DataRank · unranked

0 citations

Tatiana Kochetkov, Shangde Cai, Jiyuan Wu, Mikhail Shamis, Jayasree Nair +7 more

Data from Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses

(2023)10.1158/2326-6066.c.6550395

N/A

0DataRank · unranked

0 citations

Jaclyn E. McCloskey, Huan Yang, Janusz Puc, Yago Alcaina, Yogindra Vedvyas +7 more

Data from SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

(2023)10.1158/2159-8290.c.6548987.v1

N/A

0DataRank · unranked

0 citations

Luis J. Leandro‐García, Jesper L.V. Mååg, Vatche Tchekmedyian, Gnana P. Krishnamoorthy, Prasanna P. Tamarapu +13 more

Data from Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses

(2023)10.1158/2326-6066.c.6550395.v1

N/A

0DataRank · unranked

0 citations

Jaclyn E. McCloskey, Huan Yang, Janusz Puc, Yago Alcaina, Yogindra Vedvyas +7 more

2233MO CDC7 inhibition constrains lineage plasticity and prevents resistance and neuroendocrine transformation in the lung and prostate

Annals of Oncology(2023)10.1016/j.annonc.2023.09.1261

N/A

0DataRank · unranked

0 citations

Samir Zaidi, Wouter R. Karthaus, Yuan Zhan, Martin M. Shafer, Juan Qiu +5 more

Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0110

N/A

0DataRank · unranked

45 citations

Daniel Cameron, Helen S. Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti +11 more

EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0187

N/A

0DataRank · unranked

493 citations

Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato +24 more

Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer

Nature Communications(2024)10.1038/s41467-024-50063-z

N/A

0DataRank · unranked

35 citations

Philip H. Choi, Yu Chi Yang, Jacob A. Boyer, Adele Whaley, Priya Pancholi +16 more

SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01572-3

N/A

0DataRank · unranked

34 citations

Harsha Sridhar, Yingqian A. Zhan, Barbara P. Mello, Hong Zhong, Vidushi Durani +11 more

EGFR-directed antibodies promote HER2 ADC internalization and efficacy

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101792

N/A

0DataRank · unranked

31 citations

Flavia Michelini, Hong Shao, Celine Yeh, Joshua Z. Drago, Dazhi Liu +12 more

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Cancer Discovery(2020)10.1158/2159-8290.cd-19-0116

N/A

0DataRank · unranked

159 citations

Saber Tadros, Matt Teater, Lorena Fontán, Aaron Y. Chang, Neeraj Jain +24 more

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation

Cancer Cell(2020)10.1016/j.ccell.2020.03.001

N/A

0DataRank · unranked

166 citations

Chuanli Zhou, Xiaoling Li, Spencer Barnes, Su Deng, Elizabeth Hoover +27 more

HER2 Antibody–Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1835

N/A

0DataRank · unranked

19 citations

Christopher A. Febres‐Aldana, Zebing Liu, Jenna-Marie Dix, Ryan Cheng, Raymond G. Dematteo +13 more

Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents

British Journal of Cancer(2024)10.1038/s41416-024-02760-1

N/A

0DataRank · unranked

13 citations

Valentina Foglizzo, Guilherme Harada, Matteo Repetto, Amanda Kulick, Elisa de Stanchina +17 more

A Targetable Secreted Neural Protein Drives Pancreatic Cancer Metastatic Colonization and HIF1α Nuclear Retention

Cancer Discovery(2024)10.1158/2159-8290.cd-23-1323

N/A

0DataRank · unranked

12 citations

Y. Gloria Wu, Ethan Ravetch, M Takahashi, Abdul G. Khan, Akimasa Hayashi +8 more

Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101852

N/A

0DataRank · unranked

11 citations

Utsav Sen, Kedwin Ventura, Vrinda Jethalia, Charles Coleman, Subhasree Sridhar +13 more

SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma

The Journal of Experimental Medicine(2024)10.1084/jem.20231143

N/A

0DataRank · unranked

11 citations

Shenqiu Wang, Sara Parsa, Man Jiang, Alexander N. Gorelick, Sagarajit Mohanty +14 more

TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200862

N/A

0DataRank · unranked

9 citations

Daniel Hirschhorn, Meixian S Tang, Terence J. Purdon, Yacine Marouf, Alessandra Piersigilli +10 more

uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence

Journal of Nuclear Medicine(2024)10.2967/jnumed.124.268278

N/A

0DataRank · unranked

4 citations

Riccardo Mezzadra, Amanda Kulick, Spencer Kaminsky, Zachary V. Samuels, Angelique Loor +4 more

Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells

Biomedicine & Pharmacotherapy(2024)10.1016/j.biopha.2024.117605

N/A

0DataRank · unranked

4 citations

Sang Gyu Lee, Eeva‐Christine Brockmann, M. Jason de la Cruz, Yehuda Goldgur, Rachelle Mendoza +10 more

Augmenting CAR T-cell Functions with LIGHT

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0246

N/A

0DataRank · unranked

4 citations

Kento Tanaka, Xiaoli Mi, Vinagolu K. Rajasekhar, Jonathan F. Khan, Sarah Yoo +15 more

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.08.593195

N/A

0DataRank · unranked

2 citations

Malvika Sharma, M. Dorso, Nicholas Mai, Corina Amor, Jason Reiter +21 more

Phosphorylation-Driven Epichaperome Assembly: A Critical Regulator of Cellular Adaptability and Proliferation

Research Square(2024)10.21203/rs.3.rs-4114038/v1

N/A

0DataRank · unranked

1 citations

Seth McNutt, Tanaya Roychowdhury, Chiranjeevi Pasala, Hieu Nguyen, Daniel Thorton +27 more

228P SMARCA4 inactivation drives aggressiveness in STK11/KEAP1 co-mutant lung adenocarcinomas through the induction of TGFβ signaling

ESMO Open(2024)10.1016/j.esmoop.2024.102878

N/A

0DataRank · unranked

0 citations

Érico T. Costa, Corrin Wohlheiter, Samuel Tischfield, Esther Redín, Harsha Sridhar +15 more

Diet induced insulin resistance is due to induction of PTEN expression

Research Square(2024)10.21203/rs.3.rs-4021885/v1

N/A

0DataRank · unranked

0 citations

Radha Mukherjee, Priya Pancholi, Malvika Sharma, Hilla Solomon, Merna N. Timaul +11 more

SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma

Cancer Research(2025)10.1158/0008-5472.can-24-2745

N/A

0DataRank · unranked

27 citations

Charles Coleman, Nishant Gandhi, Vrinda Jethalia, Deniz Demircioğlu, Andrew Elliott +9 more

Metabolic engineering to facilitate anti-tumor immunity

Cancer Cell(2025)10.1016/j.ccell.2025.02.004

N/A

0DataRank · unranked

22 citations

Patrick Wallisch, Yixuan Zhao, Yating Wang, Lyric Haughton, Rachel Chirayil +10 more

Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding

Cancer Discovery(2025)10.1158/2159-8290.cd-25-0647

N/A

0DataRank · unranked

21 citations

Avantika Gupta, Nicholas Mai, Sharanya Nag, Joshua Lau, Sukrit Singh +12 more

A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1425

N/A

0DataRank · unranked

15 citations

Riccardo Mezzadra, Exequiel M. Sisso, Felix Mbuga, Rashi Raghulan, Almudena Chaves Perez +15 more

Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0614

N/A

0DataRank · unranked

12 citations

Dinesh Kumar, Santiago Garcia Borrego, Tessa Seale, Giulia Maddalena, Riccardo Mezzadra +19 more

RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs

The Journal of Experimental Medicine(2025)10.1084/jem.20241029

N/A

0DataRank · unranked

9 citations

Anthony Glover, Brian R. Untch, Nickole Sigcha‐Coello, Bin Xu, Dina Vukel +15 more

eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2424286122

N/A

0DataRank · unranked

9 citations

Ezra Y. Rosen, Malvika Sharma, M. Dorso, Nicholas Mai, Corina Amor +22 more

TROP2 expression and therapeutic targeting in uterine carcinosarcoma

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.590

N/A

0DataRank · unranked

6 citations

Higinio Dopeso, David N. Brown, Hunter Green, Kaitlyn Gill, Julia Tengelin +16 more

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas

Journal of Clinical Investigation(2025)10.1172/jci179282

N/A

0DataRank · unranked

5 citations

Helen S. Mueller, Daniel Cameron, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti +12 more

Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers

Journal of Clinical Investigation(2025)10.1172/jci191781

N/A

0DataRank · unranked

0 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more

RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.19.677259

N/A

0DataRank · unranked

0 citations

Tom Zhang, Ryan R. Cheng, Marissa S. Mattar, Juan Luis Gomez Marti, Leo Gili +12 more

Targeting Tumor Microenvironment–Derived NRG1-HER2/3 Signaling with Zenocutuzumab Restores Sensitivity to AR Inhibition in PTEN Wild-type Prostate Cancer

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-25-0505

N/A

0DataRank · unranked

0 citations

Young Sun Lee, Ninghui Mao, Nazifa Salsabeel, Zeda Zhang, Harshaminder Kaur +7 more

Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

Cancer Research(2021)10.1158/0008-5472.can-20-2929

N/A

0DataRank · unranked

39 citations

Jianan Lin, Nicolas Lecomte, Prathibha Mohan, Gokce Askan, Viraj R. Sanghvi +21 more

Patient-derived xenograft models of Fanconi anemia–associated head and neck cancer identify personalized therapeutic strategies

Journal of Clinical Investigation(2025)10.1172/jci195334

N/A

0DataRank · unranked

0 citations

Hua Li, Benjamin A Harrison, Andrew Webster, Joanna Pucilowska, Austin Nguyen +21 more

Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis

Cell Reports(2021)10.1016/j.celrep.2021.109870

N/A

0DataRank · unranked

39 citations

Loredana Moro, Rui Qu, Daniele Simoneschi, Hyunwoo Cho, Shaowen Jiang +6 more

MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

iScience(2021)10.1016/j.isci.2021.103224

N/A

0DataRank · unranked

39 citations

Christopher H. Hulton, Emily A. Costa, Vidushi Durani, Megan Little, Xiaoping Chen +11 more

Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling

Disease Models & Mechanisms(2021)10.1242/dmm.047621

N/A

0DataRank · unranked

33 citations

Igor Odintsov, Zebing Liu, Allan J.W. Lui, Takuo Hayashi, Morana Vojnic +22 more

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

Cell(2021)10.1016/j.cell.2021.07.028

N/A

0DataRank · unranked

46 citations

John P. Morris, Riccardo Mezzadra, James M. Russell, Josef Leibold, Paul B. Romesser +15 more

Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers

Nature Communications(2021)10.1038/s41467-021-25341-9

N/A

0DataRank · unranked

30 citations

Zeda Zhang, Young Sun Lee, Danielle Choi, Aura Agudelo Rivera, Dan Li +13 more

Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer

Communications Biology(2021)10.1038/s42003-021-02842-3

N/A

0DataRank · unranked

26 citations

Erica DaGama Gomes, Tai Wang, Adriana Corben, Tony Taldone, Srinivasa Gandu +35 more

Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells

Translational Oncology(2021)10.1016/j.tranon.2021.101265

N/A

0DataRank · unranked

22 citations

Kai Xu, Zhongyu Zhu, Dorothea Robev, Teja Kalidindi, Yan Xu +6 more

ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100350

N/A

0DataRank · unranked

24 citations

Scott K. Thompson, Roger A. Smith, Mariana Da Silva Ferreira, Zahra Asgari, Andrea Knežević +7 more

Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers

Endocrine Related Cancer(2021)10.1530/erc-21-0017

N/A

0DataRank · unranked

18 citations

Jennifer R. Cracchiolo, Gnana P. Krishnamoorthy, Luis J. Leandro‐García, James Nagarajah, Mahesh Saqcena +11 more

ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1798

N/A

0DataRank · unranked

50 citations

Kyeara N. Mack, Alessandra Piersigilli, Jacob Pourat, Kimberly J. Edwards, Outi Keinänen +11 more

Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.02.429407

N/A

0DataRank · unranked

4 citations

Sheela Prasad, Lou Baudrier, Michael A. Badgley, Yuyang Liu, Konnor La +12 more

Elisa de Stanchina

Indexed papers

Top data-sharing exemplar

Papers